Finanzen von CureVac NV (CVAC)CVACCureVac NV

Evaluating the bottom line, CureVac NV maintains a gross margin of 99.31%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 573.04%, while the net margin is 504.73%. These profitability ratios, combined with a Return on Equity (ROE) of 16.14%, provide a clear picture of how effectively CVAC converts its operational activities into shareholder value.

In the context of the broader market, CVAC competes directly with industry leaders such as URGN and XNCR. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, CVAC's gross margin of 99.31% stands against URGN's 90.93% and XNCR's 100.00%. Such benchmarking helps identify whether CureVac NV is trading at a premium or discount relative to its financial performance.